MAIA Biotechnology, Inc. Operating Cash Flow
MAIA Biotechnology, Inc. (MAIA) reported Operating Cash Flow of -$12.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-10
- MAIA Biotechnology, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$6.75M.
- MAIA Biotechnology, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$5.31M.
- MAIA Biotechnology, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$7.02M.
- MAIA Biotechnology, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.49M.
- MAIA Biotechnology, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$18.84M.
- MAIA Biotechnology, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$15.70M.
- MAIA Biotechnology, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$13.07M.
- MAIA Biotechnology, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$12.10M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$6.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$12.06M 10-Q · filed 2026-08-10 | -$19.08M derived: sum of 3 quarters · filed 2026-08-10 | -$22.57M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | -$5.31M 10-Q · filed 2026-05-11 | -$12.33M derived: sum of 2 quarters · filed 2026-05-11 | -$15.82M derived: sum of 3 quarters · filed 2026-05-11 | -$19.95M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | -$7.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$10.51M derived: sum of 2 quarters · filed 2026-03-23 | -$14.64M derived: sum of 3 quarters · filed 2026-08-10 | -$18.84M 10-K · filed 2026-03-23 | |
| 2025-09-30 | -$3.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$7.62M derived: sum of 2 quarters · filed 2026-08-10 | -$11.82M 10-Q · filed 2025-11-07 | -$15.73M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | -$4.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$8.34M 10-Q · filed 2026-08-10 | -$12.25M derived: sum of 3 quarters · filed 2026-08-10 | -$15.77M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | -$4.20M 10-Q · filed 2026-05-11 | -$8.11M derived: sum of 2 quarters · filed 2026-05-11 | -$11.64M derived: sum of 3 quarters · filed 2026-05-11 | -$16.32M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | -$3.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$7.43M derived: sum of 2 quarters · filed 2026-03-23 | -$12.12M derived: sum of 3 quarters · filed 2026-03-23 | -$15.70M 10-K · filed 2026-03-23 | |
| 2024-09-30 | -$3.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$8.21M derived: sum of 2 quarters · filed 2025-11-07 | -$11.80M 10-Q · filed 2025-11-07 | -$15.79M derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | -$4.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$8.27M 10-Q · filed 2025-08-11 | -$12.26M derived: sum of 3 quarters · filed 2025-08-11 | -$15.42M derived: sum of 4 quarters · filed 2025-08-11 | |
| 2024-03-31 | -$3.59M 10-Q · filed 2025-05-09 | -$7.58M derived: sum of 2 quarters · filed 2025-05-09 | -$10.74M derived: sum of 3 quarters · filed 2025-05-09 | -$13.30M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | -$3.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$7.15M derived: sum of 2 quarters · filed 2025-03-21 | -$9.71M derived: sum of 3 quarters · filed 2025-03-21 | -$13.07M 10-K · filed 2025-03-21 | |
| 2023-09-30 | -$3.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$5.72M derived: sum of 2 quarters · filed 2024-11-12 | -$9.08M 10-Q · filed 2024-11-12 | -$12.03M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$5.92M 10-Q · filed 2024-08-09 | -$8.87M derived: sum of 3 quarters · filed 2024-08-09 | -$13.19M derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | -$3.36M 10-Q · filed 2024-05-14 | -$6.31M derived: sum of 2 quarters · filed 2024-05-14 | -$10.63M derived: sum of 3 quarters · filed 2024-05-14 | -$12.65M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$2.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$7.27M derived: sum of 2 quarters · filed 2024-03-21 | -$9.29M derived: sum of 3 quarters · filed 2024-03-21 | -$12.10M 10-K · filed 2024-03-21 | -$11.66M 10-K · filed 2023-03-24 |
| 2022-09-30 | -$4.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$6.34M derived: sum of 2 quarters · filed 2023-11-07 | -$9.15M 10-Q · filed 2023-11-07 | -$10.75M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | -$2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$4.83M 10-Q · filed 2023-08-08 | -$6.43M derived: sum of 3 quarters · filed 2023-08-08 | -$7.75M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | -$2.81M 10-Q · filed 2023-05-08 | -$4.42M derived: sum of 2 quarters · filed 2023-05-08 | -$5.73M derived: sum of 3 quarters · filed 2023-05-08 | ||
| 2021-12-31 | -$1.61M derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-24 | -$2.92M derived: sum of 2 quarters · filed 2023-03-24 | -$4.12M 10-K · filed 2023-03-24 | ||
| 2021-09-30 | -$1.31M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2023-02-06 | -$2.52M 10-Q/A · filed 2023-02-06 | |||
| 2021-06-30 | -$1.20M 10-Q · filed 2022-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |